Merit Medical Systems Files 8-K on Financial Condition
Ticker: MMSI · Form: 8-K · Filed: Jan 8, 2024 · CIK: 856982
| Field | Detail |
|---|---|
| Company | Merit Medical Systems Inc (MMSI) |
| Form Type | 8-K |
| Filed Date | Jan 8, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: financial-condition, regulation-fd, corporate-governance
TL;DR
**Merit Medical Systems just dropped an 8-K on its financials, signaling an update on performance.**
AI Summary
Merit Medical Systems, Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition, as well as to make a Regulation FD disclosure. This filing indicates that the company is providing an update on its financial performance, which is crucial for investors to understand the company's current health and future prospects. For shareholders, this matters because it offers transparency into the company's recent financial activities, potentially influencing stock valuation and investment decisions.
Why It Matters
This filing provides an update on Merit Medical Systems' financial health, which is essential for investors to assess the company's performance and make informed decisions.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial information and does not inherently present new risks, but rather provides data for risk assessment.
Analyst Insight
A smart investor would review the full details of the 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure' once available to understand the specific financial updates and their potential impact on the company's valuation.
Key Players & Entities
- Merit Medical Systems, Inc. (company) — the registrant filing the 8-K
- January 8, 2024 (date) — date of earliest event reported and filing date
- 0000856982-24-000004 (other) — accession number for the filing
FAQ
What is the purpose of Merit Medical Systems, Inc.'s 8-K filing dated January 8, 2024?
The 8-K filing by Merit Medical Systems, Inc. on January 8, 2024, is for reporting on 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure', as well as 'Financial Statements and Exhibits'.
What is the registrant's business address as stated in the filing?
The registrant's business address is 1600 West Merit Parkway, South Jordan, Utah 84095.
What is the registrant's telephone number?
The registrant's telephone number is (801) 253-1600.
Under which sections of the Securities Exchange Act of 1934 was this report filed?
This report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the state of incorporation for Merit Medical Systems, Inc.?
Merit Medical Systems, Inc. is incorporated in Utah.
Filing Stats: 636 words · 3 min read · ~2 pages · Grade level 9.9 · Accepted 2024-01-08 09:05:12
Filing Documents
- mmsi-20240108x8k.htm (8-K) — 41KB
- mmsi-20240108xex99d1.htm (EX-99.1) — 59KB
- mmsi-20240108x8k001.jpg (GRAPHIC) — 11KB
- mmsi-20240108xex99d1001.jpg (GRAPHIC) — 32KB
- 0000856982-24-000004.txt ( ) — 299KB
- mmsi-20240108.xsd (EX-101.SCH) — 3KB
- mmsi-20240108_lab.xml (EX-101.LAB) — 15KB
- mmsi-20240108_pre.xml (EX-101.PRE) — 9KB
- mmsi-20240108x8k_htm.xml (XML) — 5KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition . On January 8, 2024, Merit Medical Systems, Inc. (the "Company") issued a press release reporting its projected unaudited revenue earned for the year ended December 31, 2023 and timing to announce its fourth quarter and year end 2023 results and fiscal year 2024 guidance. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure . The information contained in Item 2.02 and Item 7.01 of this Current Report on Form 8-K (including the exhibit attached hereto) is furnished pursuant to General Instruction B.2. of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act. The Company is making reference to a non-GAAP financial measure in the press release attached as Exhibit 99.1 to this report. Reconciliation of this non-GAAP financial measure to the comparable GAAP financial measure is included in the press release.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits EXHIBIT NUMBER DESCRIPTION 99.1 Press Release, dated January 8, 2024, entitled "Merit Medical Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023 and Plans to Announce Fourth Quarter and Year End 2023 Results and Issue Fiscal Year 2024 Guidance on February 28, 2024". 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MERIT MEDICAL SYSTEMS, INC. Date: January 8, 2024 By: /s/ Brian G. Lloyd Brian G. Lloyd Chief Legal Officer and Corporate Secretary 3